Cancer evolution: A means by which tumors evade treatment

Biomedicine & Pharmacotherapy

Bairui Xu¹  Shi Li²  Hui Luo³  Xiao Zhu⁴ 

[1] Corresponding authors at: Guangdong Key Laboratory for Research and Development of Natural Drugs, The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.;Guangdong Key Laboratory for Research and Development of Natural Drugs, The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China;Guangdong Key Laboratory of Urogenital Tumor Systems and Synthetic Biology, The First Affiliated Hospital of Shenzhen University, The Second People's Hospital of Shenzhen, Shenzhen, China;Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang), Zhanjiang, China;

关键词: Key words;    Cancer evolution;    Tumor heterogeneity;    Drug resistance;    Evolution model;    Oncotherapy;   

DOI  :  

来源: DOAJ

【 摘 要 】

Although various methods have been tried to study and treat cancer, the cancer remains a major challenge for human medicine today. One important reason for this is the presence of cancer evolution. Cancer evolution is a process in which tumor cells adapt to the external environment, which can suppress the human immune system's ability to recognize and attack tumors, and also reduce the reproducibility of cancer research. Among them, heterogeneity of the tumor provides intrinsic motivation for this process. Recently, with the development of related technologies such as liquid biopsy, more and more knowledge about cancer evolution has been gained and interest in this topic has also increased. Therefore, starting from the causes of tumorigenesis, this paper introduces several tumorigenesis processes and pathways, as well as treatment options for different targets.

【 授权许可】

Unknown